Sector portfolio · VC firm · China
Sherpa Healthcare Partners' Biotech portfolio
Sherpa Healthcare Partners has backed 22 Biotech startups in rounds we track, $1.1B between them, shown by the stage each has reached. The best-funded is Ausperbio.
22startups backed
5stages
$1.1Braised between them
Series Bbiggest stage
Funding by segment
- Series B$483M8
- Series A$210M6
- Stage not reported$115M3
- Series C and later$255M3
- Pre-seed and seed$41M2
Where they are based
- China14$670M
- United States7$348M
- Japan1$87M
China
United States
JapanFounded
Earlier
12
13
14
415
16
17
418
219
320
521
122
23
24
25
26
3 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M2
- $10M to $50M9
- $50M to $250M11
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
19 of 22 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- China14
- United States7
- Japan1
Startups by country, 3 countries in all.
Segment by segment
Series B
8 startups · $483M raised
AusperBioAusperBio is a clinical-stage biopharmaceutical company dedicated to advancing treatments for hepatitis B virus (HBV) and developiUnited States$113M
Singleron BiotechnologiesSingleron Biotechnologies is an innovative molecular diagnostic company.China$100M
EdiGeneEdiGene is a biotechnology company that develops genome editing technologies.Japan$87M
EpimAB BiotherapeuticsEpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company.China$74M
Starna TherapeuticsStarna Therapeutics is a biotechnology company based in Suzhou, China, founded in August 2021.China$42M
PAQ TherapeuticsPAQ Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020 by Dr.United States$38M- YCYosemite ClinicYosemite Clinic is a full-service clinic providing convinient walk-in medical services in a state-of-the-art enviroment in Central Pudong.China$15M
Hongyun BiotechHongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.China$14M
Series A
6 startups · $210M raised
Link Cell TherapiesLink Cell Therapies is a biotechnology company based in South San Francisco, founded in 2022 by Stanford physicians Robbie MajznerUnited States$60M
Appia BioAppia Bio was a biotechnology company founded in 2020 and based in Culver City, California.United States$52M
Neukio BiotherapeuticsNeukio Biotherapeutics focuses on development of next generation allogenic cell therapies via the iPSC-CAR-NK axis, through internChina$50M
BAKX TherapeuticsBAKX Therapeutics is a provider of cancer treatment.United States$25M
Shanhu HealthShanhu Health is committed to provide the highest quality digital products for clinical research, including: IP4CAST, IRT, WMS, EDChina$15MUniXell BiotechnologyUniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.China$7.2M
Stage not reported
3 startups · $115M raised
Alamar BiosciencesAlamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time.United States$50M- KPKeChow PharmaKeChow Pharma, Inc.China$45M
ImmunochinaImmunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.China$20M
Series C and later
3 startups · $255M raised
New Horizon HealthNew Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.China$96M
GRIT BiotechnologyGrit Biotechnology, also known as Grit Bio, is a clinical-stage biopharmaceutical company based in Shanghai, China.China$84M
Alebund PharmaceuticalsAlebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.China$75M
Pre-seed and seed
2 startups · $41M raised
- UUniXellUniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.China$31M
Fuse BiotherapeuticsFuse Biotherapeutics is a biotechnology company based in Woburn, Massachusetts.United States$9.5M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Sherpa Healthcare Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioTengxun Touzi's AI portfolio42 startups · $42BSector portfolioLD Capital's Web3 & Crypto portfolio41 startups · $292MSector portfolioTengxun Touzi's Fintech portfolio35 startups · $10BSector portfolioLD Capital's AI portfolio25 startups · $864MSector portfolioTengxun Touzi's Biotech portfolio25 startups · $4.0BSector portfolioLegend Capital's Biotech portfolio24 startups · $1.8B
Raising from investors like Sherpa Healthcare Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.